Filing search / Baudax Bio, Inc. / "Strategy"

424B3

BXRXQ Baudax Bio, Inc.

22 Nov 23

Prospectus supplement

4:58pm

our strategy, future operations, future financial position, future revenues, projected costs, prospects, plans and objectives of management

8-K

BXRXQ Baudax Bio, Inc.

6 Oct 23

Departure of Directors or Certain Officers

8:00am

”), at an agreed upon hourly rate. Ms. McAndrew, age 49, is a Director with Danforth, an advisory firm focused on providing financial strategy to life science

PRER14A

ud6y1b0i84

25 Aug 23

Preliminary revised proxy

4:01pm

424B5

kqckqv30yp

18 Aug 23

Prospectus supplement for primary offering

4:40pm

424B3

c85jd

17 Aug 23

Prospectus supplement

8:05am

DEFA14A

EX-99.1

jk2k upt8izv

9 Aug 23

Additional proxy soliciting materials

5:28pm

DEFA14A

EX-99.2

nl1t9gak3lp

9 Aug 23

Additional proxy soliciting materials

5:28pm

8-K/A

EX-99.2

2v9 0lqcl

9 Aug 23

Other Events

5:27pm

8-K/A

EX-99.1

u4mbcfmczpx

9 Aug 23

Other Events

5:27pm

DEFA14A

cfe5x

17 Jul 23

Additional proxy soliciting materials

7:05am

8-K

EX-99.1

pscze

17 Jul 23

Other Events

7:00am